ERBB2 and neoplasm: When used, it should be restricted to women with all of the following criteria: invasive cancer, aged >70 years, tumor <2 cm, resection margins >2 mm, grade 1— 2, pN0, ER positive, HER2 negative, L0, V0, and EIC negative.